+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A methodology for incorporating functional bone marrow sparing in IMRT planning for pelvic radiation therapy



A methodology for incorporating functional bone marrow sparing in IMRT planning for pelvic radiation therapy



RadioTherapy and Oncology 99(1): 49-54



The purpose of this study was to design a radiation therapy treatment planning approach that would spare hematopoietically active bone marrow using [(18)F]FLT PET imaging. We have developed an IMRT planning methodology to incorporate functional PET imaging using [(18)F]FLT scans. Plans were generated for two simulated cervical cancer patients, where pelvic active bone marrow regions were incorporated as avoidance regions based on the ranges: SUV4 ≥ 4; 4>SUV3 ≥ 3; and 3 > SUV2 ≥ 2. Dose objectives were set to reduce bone marrow volume that received 10 (V(10)) and 20 (V(20))Gy. Active bone marrow regions identified by [(18)F]FLT with an SUV ≥ 2, SUV ≥ 3, and SUV ≥ 4 represented an average of 43.0%, 15.3%, and 5.8%, respectively of the total osseous pelvis for the two cases studied. Improved dose-volume histograms for all identified bone marrow SUV volumes and decreases in V(10), and V(20) were achieved without clinically significant changes to PTV or OAR doses. Incorporation of [(18)F]FLT PET in IMRT planning provides a methodology to reduce radiation dose to active bone marrow without compromising PTV or OAR dose objectives in pelvic malignancies.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051160896

Download citation: RISBibTeXText

PMID: 21397965

DOI: 10.1016/j.radonc.2011.01.025


Related references

Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies. International Journal of Radiation Oncology, Biology, Physics 85(2): 406-414, 2013

Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT. International Journal of Radiation Oncology, Biology, Physics 79(4): 1043-1047, 2011

Reduced Myelotoxicity in Pelvic Malignancies With Bone Marrow Sparing IMRT. International Journal of Radiation Oncology*biology*physics 84(3): S355-S356, 2012

Incorporating 18 FDG-PET-defined pelvic active bone marrow in the automatic treatment planning process of anal cancer patients undergoing chemo-radiation. Bmc Cancer 17(1): 710, 2018

Dosimetric comparison study between intensity modulated radiation therapy and three-dimensional conformal proton therapy for pelvic bone marrow sparing in the treatment of cervical cancer. Journal of Applied Clinical Medical Physics 11(4): 3255, 2011

(P068) VMAT vs Eight-Field IMRT: Dosimetric Comparison of Pelvic Radiotherapy for High-Risk Prostate Cancer Patients in Terms of Bone Marrow Sparing. Oncology 29(4 Suppl 1): -, 2015

Intensity modulated radiation therapy (IMRT) for post-hysterectomy pelvic radiation: selection of patients and planning target volume (PTV). International Journal of Radiation Oncology*biology*physics 54(2-Supp-S): 42-43, 2002

Incorporation of SPECT bone marrow imaging into intensity modulated whole-pelvic radiation therapy treatment planning for gynecologic malignancies. RadioTherapy and Oncology 77(1): 11-17, 2005

Comparison of three IMRT inverse planning techniques that allow for partial esophagus sparing in patients receiving thoracic radiation therapy for lung cancer. Medical Dosimetry 29(3): 210-216, 2004

Comparison of three IMRT inverse planning techniques that allow partial esophagus sparing in patients receiving thoracic radiation therapy for lung cancer. International Journal of Radiation Oncology Biology Physics 54(2 Supplement): 153, 2002

Bone marrow-sparing intensity-modulated radiotherapy (IMRT) for neo-adjuvant therapy of inoperable cervical cancer in a patient with severe thrombocytopenia. Onkologie 33(4): 189-192, 2010

Functional outcome of parotid gland sparing in patients with head and neck (H&N) cancers receiving intensity-modulated (IMRT) or 3-D radiation therapy. International Journal of Radiation Oncology*biology*physics 48(3-Supp-S1): 174-0, 2000

Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans. Radiation Oncology 2: 41, 2007

Intensity-modulated radiation therapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiation therapy. International Journal of Radiation Oncology Biology Physics 51(3 Supplement 1): 220-221, 2001

A Phase II Study Evaluating Bone Marrow-Sparing, Image-guided Pelvic Intensity-Modulated Radiotherapy (IMRT) With Cesium-131 Brachytherapy Boost, Adjuvant Chemotherapy, and Long-Term Hormonal Ablation in Patients With High Risk, Nonmetastatic Prostate Cancer. American Journal of Clinical Oncology 2019, 2019